{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:39:45Z","timestamp":1753889985305,"version":"3.41.2"},"reference-count":103,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>In late 2019, a report from China was published stating a disease with an unknown cause.\nAfter that, the outbreak of the COVID-19 caused a pandemic in the world. On March 11, 2020, the\noutbreak of this virus was reported in 100 countries.\nThe virus is currently spreading rapidly around the world. In the past, coronaviruses caused lifethreatening\ndiseases such as SARS and MERS in some areas of the world. Although there is still a\ndebate about the origin of this new coronavirus, it is most likely linked with some animals, including\nbats, civet, and pangolin. In this review, we try to describe the features of the new coronavirus as well\nas the recent diagnostic and therapeutic findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526521666210322160038","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T10:58:29Z","timestamp":1616497109000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of Structural, Treatment, and Clinical Characteristics of\nCOVID-19 Along with the Challenges Caused by its Prevalence"],"prefix":"10.2174","volume":"22","author":[{"given":"Maham","family":"Doagooyan","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical\nSciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Hoda","family":"Alavizadeh","sequence":"additional","affiliation":[{"name":"Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University\nof Medical Sciences, Mashhad, Iran | Department of Pharmaceutical Nanotechnology, School of Pharmacy,\nMashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Akhtari","sequence":"additional","affiliation":[{"name":"Department of Medical Nanotechnology, School of Advanced\nTechnologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran | Toxoplasmosis Research\nCenter, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Halal Research Center of IRI, FDA, Tehran, Iran | Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences,\nMashhad, Iran | Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of\nMedical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed Ghanbari Hasan","family":"Kiade","sequence":"additional","affiliation":[{"name":"Biotechnology Faculty, Amol University of Special Modern Technologies, Amol, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pariya Haghgoo","family":"Kochesfahani","sequence":"additional","affiliation":[{"name":"Engineering Faculty, Islamic Azad University Central Tehran Branch, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Gheybi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical\nSciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0140-6736(66)92364-6","volume":"1","author":"Tyrrell D.A.","year":"1966","unstructured":"Tyrrell D.A.; Bynoe M.L.; Cultivation of viruses from a high proportion of patients with colds. Lancet 1966,1(7428),76-77","journal-title":"Lancet"},{"key":"ref=2","volume":"25","author":"Eurosurveillance Editorial T.","year":"2020","unstructured":"Eurosurveillance Editorial T.; Updated rapid risk assessment from ECDC on the novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU\/EEA and the UK. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Available from:2020,25(10) https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2020.25.10.2003121"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","volume":"24","author":"Kahn J.S.","year":"2005","unstructured":"Kahn J.S.; McIntosh K.; History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005,24(11)(Suppl.),S223-S227","journal-title":"Pediatr Infect Dis J"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vex012","volume":"3","author":"Anthony S.J.","year":"2017","unstructured":"Anthony S.J.; Johnson C.K.; Greig D.J.; Kramer S.; Che X.; Wells H.; Hicks A.L.; Joly D.O.; Wolfe N.D.; Daszak P.; Karesh W.; Lipkin W.I.; Morse S.S.; Mazet J.A.K.; Goldstein T.; Global patterns in coronavirus diversity. Virus Evol 2017,3(1)","journal-title":"Virus Evol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3346\/jkms.2020.35.e86","volume":"35","author":"Kim J.Y.","unstructured":"Kim J.Y.; Ko J.H.;  Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea2020 ,35(7),86","journal-title":"Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea2020"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"Zhu N.","year":"2020","unstructured":"Zhu N.; Zhang D.; Wang W.; Li X.; Yang B.; Song J.; Zhao X.; Huang B.; Shi W.; Lu R.; Niu P.; Zhan F.; Ma X.; Wang D.; Xu W.; Wu G.; Gao G.F.; Tan W.; A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020,382(8),727-733","journal-title":"N Engl J Med"},{"key":"ref=7","volume":"8","author":"Kolifarhood G.","year":"2020","unstructured":"Kolifarhood G.; Aghaali M.; Mozafar Saadati H.; Taherpour N.; Rahimi S.; Izadi N.; Hashemi Nazari S.S.; Epidemiological and clinical aspects of COVID-19; a narrative review. Arch Acad Emerg Med 2020,8(1)","journal-title":"Arch Acad Emerg Med"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102083","volume":"51","author":"Roy D.","year":"2020","unstructured":"Roy D.; Tripathy S.; Kar S.K.; Sharma N.; Verma S.K.; Kaushal V.; Study of knowledge, attitude, anxiety","journal-title":"Asian J Psychiatr"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"30082","DOI":"10.1016\/j.jmii.2020.03.022","volume":"S1684-1182","author":"Mousavizadeh L.","unstructured":"Mousavizadeh L.; Ghasemi S.; Genotype and phenotype of COVID-19: Their roles in pathogenesis. J. Microbiol. Immunol. Infect.,\n2020 ,S1684-1182(20),30082-7"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1128\/JVI.72.8.6838-6850.1998","volume":"72","author":"de Haan C.A.","year":"1998","unstructured":"de Haan C.A.; Kuo L.; Masters P.S.; Vennema H.; Rottier P.J.; Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol 1998,72(8),6838-6850","journal-title":"J Virol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/v2081803","volume":"2","author":"Woo P.C.","year":"2010","unstructured":"Woo P.C.; Huang Y.; Lau S.K.; Yuen K.Y.; Coronavirus genomics and bioinformatics analysis. Viruses 2010,2(8),1804-1820","journal-title":"Viruses"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40779-020-00240-0","volume":"7","author":"Guo Y-R.","year":"2020","unstructured":"Guo Y-R.; The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status. Mil Med Res 2020,7(1),1-10","journal-title":"Mil Med Res"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104285","volume":"82","author":"Li C.","year":"2020","unstructured":"Li C.; Yang Y.; Ren L.; Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect Genet Evol 2020,82","journal-title":"Infect Genet Evol"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"Lai C-C.","year":"2020","unstructured":"Lai C-C.; Shih T.P.; Ko W.C.; Tang H.J.; Hsueh P.R.; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020,55(3)","journal-title":"Int J Antimicrob Agents"},{"author":"Liu P.","key":"ref=15","unstructured":"Liu P.; Are pangolins the intermediate host of the 2019 novel\ncoronavirus (2019-nCoV)? bioRxiv, 2019. Available\nfrom  https:\/\/journals.plos.org\/plospathogens\/article?id=10.1371\/journal.ppat.1008421"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P.","year":"2020","unstructured":"Zhou P.; Yang X.L.; Wang X.G.; Hu B.; Zhang L.; Zhang W.; Si H.R.; Zhu Y.; Li B.; Huang C.L.; Chen H.D.; Chen J.; Luo Y.; Guo H.; Jiang R.D.; Liu M.Q.; Chen Y.; Shen X.R.; Wang X.; Zheng X.S.; Zhao K.; Chen Q.J.; Deng F.; Liu L.L.; Yan B.; Zhan F.X.; Wang Y.Y.; Xiao G.F.; Shi Z.L.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020,579(7798),270-273","journal-title":"Nature"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; Kr\u00fcger N.; Herrler T.; Erichsen S.; Schiergens T.S.; Herrler G.; Wu N.H.; Nitsche A.; M\u00fcller M.A.; Drosten C.; P\u00f6hlmann S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280.e8","journal-title":"Cell"},{"key":"ref=18","first-page":"1260","volume":"367","author":"Wrapp D.","year":"2020","unstructured":"Wrapp D.; Wang N.; Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. 2020,367(6483),1260-1263"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-323-52727-9.00008-X","author":"Javadzadeh Y.","year":"2017","unstructured":"Javadzadeh Y.; Bahari L.A.;  Therapeutic nanostructures for dermal and transdermal drug delivery Nano-and Microscale Drug Delivery Systems 2017,131-146","journal-title":"Therapeutic nanostructures for dermal and transdermal drug delivery Nano-and Microscale Drug Delivery Systems"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-virology-100114-055218","volume":"2","author":"Sola I.","year":"2015","unstructured":"Sola I.; Almaz\u00e1n F.; Z\u00fa\u00f1iga S.; Enjuanes L.; Continuous and discontinuous RNA synthesis in coronaviruses. Annu Rev Virol 2015,2(1),265-288","journal-title":"Annu Rev Virol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","volume":"7","author":"Tang X.","year":"2020","unstructured":"Tang X.; On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 2020,7(6),1012-1023","journal-title":"Natl Sci Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1148\/radiol.2020200236","volume":"295","author":"Lei J.","year":"2020","unstructured":"Lei J.; Li J.; Li X.; Qi X.; CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020,295(1),18-18","journal-title":"Radiology"},{"key":"ref=23","first-page":"988","volume":"12","author":"Alemdar E.","unstructured":"Alemdar E.;  Chronobiological Treatment Approach in COVID-19; ,12(4),988"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Ren L.; Zhao J.; Hu Y.; Zhang L.; Fan G.; Xu J.; Gu X.; Cheng Z.; Yu T.; Xia J.; Wei Y.; Wu W.; Xie X.; Yin W.; Li H.; Liu M.; Xiao Y.; Gao H.; Guo L.; Xie J.; Wang G.; Jiang R.; Gao Z.; Jin Q.; Wang J.; Cao B.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","volume":"13","author":"Assiri A.","year":"2013","unstructured":"Assiri A.; Al-Tawfiq J.A.; Al-Rabeeah A.A.; Al-Rabiah F.A.; Al-Hajjar S.; Al-Barrak A.; Flemban H.; Al-Nassir W.N.; Balkhy H.H.; Al-Hakeem R.F.; Makhdoom H.Q.; Zumla A.I.; Memish Z.A.; Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013,13(9),752-761","journal-title":"Lancet Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa030685","volume":"348","author":"Lee N.","year":"2003","unstructured":"Lee N.; Hui D.; Wu A.; Chan P.; Cameron P.; Joynt G.M.; Ahuja A.; Yung M.Y.; Leung C.B.; To K.F.; Lui S.F.; Szeto C.C.; Chung S.; Sung J.J.; A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003,348(20),1986-1994","journal-title":"N Engl J Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1056\/NEJMc2001272","volume":"382","author":"Phan L.T.","year":"2020","unstructured":"Phan L.T.; Nguyen T.V.; Luong Q.C.; Nguyen T.V.; Nguyen H.T.; Le H.Q.; Nguyen T.T.; Cao T.M.; Pham Q.D.; Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med 2020,382(9),872-874","journal-title":"N Engl J Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Bai Y.","year":"2020","unstructured":"Bai Y.; Yao L.; Wei T.; Tian F.; Jin D.Y.; Chen L.; Wang M.; Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020,323(14),1406-1407","journal-title":"JAMA"},{"key":"ref=29","author":"Organization W.H.","year":"2020","unstructured":"Organization W.H.;  Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020 2020","journal-title":"Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020"},{"key":"ref=30","first-page":"3404","volume":"24","author":"Zheng F.","year":"2020","unstructured":"Zheng F.; Tang W.; Li H.; Huang Y.X.; Xie Y.L.; Zhou Z.G.; Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci 2020,24(6),3404-3410","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/ajt.15891","volume":"20","author":"Gandolfini I.","year":"2020","unstructured":"Gandolfini I.; Delsante M.; Fiaccadori E.; Zaza G.; Manenti L.; Degli Antoni A.; Peruzzi L.; Riella L.V.; Cravedi P.; Maggiore U.; COVID-19 in kidney transplant recipients. Am J Transplant 2020,20(7),1941-1943","journal-title":"Am J Transplant"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1001\/jama.2020.8259","volume":"323","author":"Sethuraman N.","year":"2020","unstructured":"Sethuraman N.; Jeremiah S.S.; Ryo A.; Interpreting diagnostic tests for SARS-CoV-2. JAMA 2020,323(22),2249-2251","journal-title":"JAMA"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104446","volume":"129","author":"Kitagawa Y.","year":"2020","unstructured":"Kitagawa Y.; Orihara Y.; Kawamura R.; Imai K.; Sakai J.; Tarumoto N.; Matsuoka M.; Takeuchi S.; Maesaki S.; Maeda T.; Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification. J Clin Virol 2020,129","journal-title":"J Clin Virol"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104417","volume":"128","author":"Wehrhahn M.C.","year":"2020","unstructured":"Wehrhahn M.C.; Robson J.; Brown S.; Bursle E.; Byrne S.; New D.; Chong S.; Newcombe J.P.; Siversten T.; Hadlow N.; Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic. J Clin Virol 2020,128","journal-title":"J Clin Virol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.2174\/0929867325666180831150259","volume":"26","author":"Arrighetti N.","year":"2019","unstructured":"Arrighetti N.; Corbo C.; Evangelopoulos M.; Past\u00f2 A.; Zuco V.; Tasciotti E.; Exosome-like nanovectors for drug delivery in cancer. Curr Med Chem 2019,26(33),6132-6148","journal-title":"Curr Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"Okba N.M.A.","year":"2020","unstructured":"Okba N.M.A.; M\u00fcller M.A.; Li W.; Wang C.; GeurtsvanKessel, C.H.; Corman, V.M.; Lamers, M.M.; Sikkema, R.S.; de Bruin, E.; Chandler, F.D.; Yazdanpanah, Y.; Le Hingrat, Q.; Descamps, D.; Houhou-Fidouh, N.; Reusken, C.B.E.M.; Bosch, B.J.; Drosten, C.; Koopmans, M.P.G.; Haagmans, B.L. Severe acute respiratory syndrome coronavirus 2\u2212 specific antibody responses in coronavirus disease patients. Emerg Infect Dis 2020,26(7),1478-1488","journal-title":"Emerg Infect Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/ijms21020684","volume":"21","author":"Bian Y.","year":"2020","unstructured":"Bian Y.; Wei J.; Zhao C.; Li G.; Natural polyphenols targeting senescence: a novel prevention and therapy strategy for cancer. Int J Mol Sci 2020,21(2),684","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/17425247.2020.1713746","volume":"17","author":"Askarizadeh A.","unstructured":"Askarizadeh A.; Badiee A.; Khamesipour A.J.E.O.o.D.D.;  Development of nano-carriers for Leishmania vaccine delivery2020 ,17(2),167-187","journal-title":"Development of nano-carriers for Leishmania vaccine delivery2020"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","volume":"507","author":"Padoan A.","year":"2020","unstructured":"Padoan A.; Sciacovelli L.; Basso D.; Negrini D.; Zuin S.; Cosma C.; Faggian D.; Matricardi P.; Plebani M.; IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study. Clin Chim Acta 2020,507,164-166","journal-title":"Clin Chim Acta"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1469-0691.2004.01009.x","volume":"10","author":"Hsueh P-R.","year":"2004","unstructured":"Hsueh P-R.; Huang L.M.; Chen P.J.; Kao C.L.; Yang P.C.; Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect 2004,10(12),1062-1066","journal-title":"Clin Microbiol Infect"},{"first-page":"1","author":"Ramsey A.W.a.L.","key":"ref=41","unstructured":"Ramsey A.W.a.L.; .Many of the coronavirus' most mysterious and\ndangerous symptoms have one thing in common: blood clots. This\nisn't solely a respiratory infection. 2020; ,1-13"},{"key":"ref=42","first-page":"1","author":"Bi Q.","year":"2020","unstructured":"Bi Q.;  Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts 2020,1-21","journal-title":"Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"e4208","DOI":"10.1093\/cid\/ciaa270","volume":"73","author":"Mo P.","year":"2021","unstructured":"Mo P.; Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2021,73(11),e4208-13","journal-title":"Clin Infect Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","volume":"9","author":"Tian X.","year":"2020","unstructured":"Tian X.; Li C.; Huang A.; Xia S.; Lu S.; Shi Z.; Lu L.; Jiang S.; Yang Z.; Wu Y.; Ying T.; Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect 2020,9(1),382-385","journal-title":"Emerg Microbes Infect"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","volume":"66","author":"Masters P.S.","year":"2006","unstructured":"Masters P.S.; The molecular biology of coronaviruses. Adv Virus Res 2006,66,193-292","journal-title":"Adv Virus Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/v11010041","volume":"11","author":"Banerjee A.","year":"2019","unstructured":"Banerjee A.; Kulcsar K.; Misra V.; Frieman M.; Mossman K.; Bats and Coronaviruses. Viruses 2019,11(1),41","journal-title":"Viruses"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"Li F.","year":"2016","unstructured":"Li F.; Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 2016,3(1),237-261","journal-title":"Annu Rev Virol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.12688\/f1000research.22211.2","volume":"9","author":"Kruse R.L.","year":"2020","unstructured":"Kruse R.L.; Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000 Res 2020,9,72","journal-title":"F1000 Res"},{"key":"ref=49","first-page":"10","volume":"38","author":"Shanmugaraj B.","year":"2020","unstructured":"Shanmugaraj B.; Siriwattananon K.; Wangkanont K.; Phoolcharoen W.; Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol 2020,38(1),10-18","journal-title":"Asian Pac J Allergy Immunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","volume":"79","author":"Sui J.","year":"2005","unstructured":"Sui J.; Li W.; Roberts A.; Matthews L.J.; Murakami A.; Vogel L.; Wong S.K.; Subbarao K.; Farzan M.; Marasco W.A.; Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol 2005,79(10),5900-5906","journal-title":"J Virol"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101652","volume":"37","author":"Daw M.A.","year":"2020","unstructured":"Daw M.A.; Corona virus infection in Syria, Libya and Yemen; an alarming devastating threat. Travel Med Infect Dis 2020,37","journal-title":"Travel Med Infect Dis"},{"key":"ref=52","author":"Yousefzadegan S.","year":"2020","unstructured":"Yousefzadegan S.; Rezaei N.; Case Report: Death Due to Novel Coronavirus Disease (COVID-19) in Three Brothers. Am J Trop Med Hyg 2020","journal-title":"Am J Trop Med Hyg"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Zhu F.; Liu X.; Zhang J.; Wang B.; Xiang H.; Cheng Z.; Xiong Y.; Zhao Y.; Li Y.; Wang X.; Peng Z.; Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA 2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"Chan J.F-W.","year":"2020","unstructured":"Chan J.F-W.; Yuan S.; Kok K.H.; To K.K.; Chu H.; Yang J.; Xing F.; Liu J.; Yip C.C.; Poon R.W.; Tsoi H.W.; Lo S.K.; Chan K.H.; Poon V.K.; Chan W.M.; Ip J.D.; Cai J.P.; Cheng V.C.; Chen H.; Hui C.K.; Yuen K.Y.; A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020,395(10223),514-523","journal-title":"Lancet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.32598\/jpr.8.2.139","volume":"8","author":"Rahimzadeh G.","year":"2020","unstructured":"Rahimzadeh G.; COVID-19 infection in Iranian children: a case series of 9 patients. J Ped Rev 2020,8(2),139-144","journal-title":"J Ped Rev"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/tp.2020.02.06","volume":"9","author":"Zhu H.","year":"2020","unstructured":"Zhu H.; Wang L.; Fang C.; Peng S.; Zhang L.; Chang G.; Xia S.; Zhou W.; Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020,9(1),51-60","journal-title":"Transl Pediatr"},{"author":"Farahnak Assadi M.D.","key":"ref=57","unstructured":"Farahnak Assadi M.D.; chgeck this?"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JVI.01248-09","volume":"84","author":"Glowacka I.","year":"2010","unstructured":"Glowacka I.; Bertram S.; Herzog P.; Pfefferle S.; Steffen I.; Muench M.O.; Simmons G.; Hofmann H.; Kuri T.; Weber F.; Eichler J.; Drosten C.; P\u00f6hlmann S.; Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol 2010,84(2),1198-1205","journal-title":"J Virol"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00749-2020","volume":"55","author":"Cristiani L.","year":"2020","unstructured":"Cristiani L.; Mancino E.; Matera L.; Nenna R.; Pierangeli A.; Scagnolari C.; Midulla F.; Will children reveal their secret? The coronavirus dilemma. Eur Respir J 2020,55(4)","journal-title":"Eur Respir J"},{"key":"ref=60","volume":"19","author":"Chen J.","year":"2020","unstructured":"Chen J.; Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation. Aging Cell 2020,19(7)","journal-title":"Aging Cell"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ptr.6700","volume":"34","author":"Islam M.T.","year":"2020","unstructured":"Islam M.T.; Sarkar C.; El-Kersh D.M.; Jamaddar S.; Uddin S.J.; Shilpi J.A.; Mubarak M.S.; Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytother Res 2020,34(10),2471-2492","journal-title":"Phytother Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","volume":"67","author":"Li S.Y.","year":"2005","unstructured":"Li S.Y.; Chen C.; Zhang H.Q.; Guo H.Y.; Wang H.; Wang L.; Zhang X.; Hua S.N.; Yu J.; Xiao P.G.; Li R.S.; Tan X.; Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005,67(1),18-23","journal-title":"Antiviral Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jep.2008.03.018","volume":"118","author":"Lau K-M.","year":"2008","unstructured":"Lau K-M.; Lee K.M.; Koon C.M.; Cheung C.S.; Lau C.P.; Ho H.M.; Lee M.Y.; Au S.W.; Cheng C.H.; Lau C.B.; Tsui S.K.; Wan D.C.; Waye M.M.; Wong K.B.; Wong C.K.; Lam C.W.; Leung P.C.; Fung K.P.; Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol 2008,118(1),79-85","journal-title":"J Ethnopharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jep.2008.07.048","volume":"120","author":"Chen C-J.","year":"2008","unstructured":"Chen C-J.; Michaelis M.; Hsu H.K.; Tsai C.C.; Yang K.D.; Wu Y.C.; Cinatl J.; Doerr H.W.; Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol 2008,120(1),108-111","journal-title":"J Ethnopharmacol"},{"key":"ref=65","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2012.45.4.221","author":"Kim D-C.","year":"2012","unstructured":"Kim D-C.; Ku S-K.; Bae J-S.; Anticoagulant activities of curcumin and its derivative. In Vivo 2012","journal-title":"In Vivo"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1055\/s-0038-1642645","volume":"73","author":"Davie E.W.","year":"1995","unstructured":"Davie E.W.;  Biochemical and molecular aspects of the coagulation cascadeThrombosis and haemostasis, 1995,73(01),001-006","journal-title":"Biochemical and molecular aspects of the coagulation cascadeThrombosis and haemostasis,"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1021\/bi00107a001","volume":"30","author":"Davie E.W.","year":"1991","unstructured":"Davie E.W.; Fujikawa K.; Kisiel W.; The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991,30(43),10363-10370","journal-title":"Biochemistry"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.bcp.2008.08.008","volume":"76","author":"Anand P.","year":"2008","unstructured":"Anand P.; Thomas S.G.; Kunnumakkara A.B.; Sundaram C.; Harikumar K.B.; Sung B.; Tharakan S.T.; Misra K.; Priyadarsini I.K.; Rajasekharan K.N.; Aggarwal B.B.; Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008,76(11),1590-1611","journal-title":"Biochem Pharmacol"},{"key":"ref=69","author":"Xu Z.","year":"2020","unstructured":"Xu Z.; Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020","journal-title":"bioRxiv"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/bst.2020.01020","volume":"14","author":"Lu H.","year":"2020","unstructured":"Lu H.; Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020,14(1),69-71","journal-title":"Biosci Trends"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","volume":"14","author":"Dong L.","year":"2020","unstructured":"Dong L.; Hu S.; Gao J.; Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020,14(1),58-60","journal-title":"Drug Discov Ther"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"Rothan H.A.","year":"2020","unstructured":"Rothan H.A.; Byrareddy S.N.; The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020,109","journal-title":"J Autoimmun"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Zhang D.; Du G.; Du R.; Zhao J.; Jin Y.; Fu S.; Gao L.; Cheng Z.; Lu Q.; Hu Y.; Luo G.; Wang K.; Lu Y.; Li H.; Wang S.; Ruan S.; Yang C.; Mei C.; Wang Y.; Ding D.; Wu F.; Tang X.; Ye X.; Ye Y.; Liu B.; Yang J.; Yin W.; Wang A.; Fan G.; Zhou F.; Liu Z.; Gu X.; Xu J.; Shang L.; Zhang Y.; Cao L.; Guo T.; Wan Y.; Qin H.; Jiang Y.; Jaki T.; Hayden F.G.; Horby P.W.; Cao B.; Wang C.; Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020,395(10236),1569-1578","journal-title":"Lancet"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100059","volume":"1","author":"Pizzorno A.","year":"2020","unstructured":"Pizzorno A.; Padey B.; Julien T.; Trouillet-Assant S.; Traversier A.; Errazuriz-Cerda E.; Fouret J.; Dubois J.; Gaymard A.; Lescure F.X.; Duli\u00e8re V.; Brun P.; Constant S.; Poissy J.; Lina B.; Yazdanpanah Y.; Terrier O.; Rosa-Calatrava M.; Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep Med 2020,1(4)","journal-title":"Cell Rep Med"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","author":"Beigel J.H.","year":"2020","unstructured":"Beigel J.H.; Remdesivir for the treatment of Covid-19\u2014preliminary report. N Engl J Med 2020","journal-title":"N Engl J Med"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax5866","volume":"11","author":"Toots M.","year":"2019","unstructured":"Toots M.; Yoon J.J.; Cox R.M.; Hart M.; Sticher Z.M.; Makhsous N.; Plesker R.; Barrena A.H.; Reddy P.G.; Mitchell D.G.; Shean R.C.; Bluemling G.R.; Kolykhalov A.A.; Greninger A.L.; Natchus M.G.; Painter G.R.; Plemper R.K.; Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci Transl Med 2019,11(515)","journal-title":"Sci Transl Med"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030343","volume":"3","author":"Stockman L.J.","year":"2006","unstructured":"Stockman L.J.; Bellamy R.; Garner P.; SARS: systematic review of treatment effects. PLoS Med 2006,3(9)","journal-title":"PLoS Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"Hung I.F-N.","year":"2020","unstructured":"Hung I.F-N.; Lung K.C.; Tso E.Y.; Liu R.; Chung T.W.; Chu M.Y.; Ng Y.Y.; Lo J.; Chan J.; Tam A.R.; Shum H.P.; Chan V.; Wu A.K.; Sin K.M.; Leung W.S.; Law W.L.; Lung D.C.; Sin S.; Yeung P.; Yip C.C.; Zhang R.R.; Fung A.Y.; Yan E.Y.; Leung K.H.; Ip J.D.; Chu A.W.; Chan W.M.; Ng A.C.; Lee R.; Fung K.; Yeung A.; Wu T.C.; Chan J.W.; Yan W.W.; Chan W.M.; Chan J.F.; Lie A.K.; Tsang O.T.; Cheng V.C.; Que T.L.; Lau C.S.; Chan K.H.; To K.K.; Yuen K.Y.; Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020,395(10238),1695-1704","journal-title":"Lancet"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10096-005-0004-z","volume":"24","author":"Lai S.T.","year":"2005","unstructured":"Lai S.T.; Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis 2005,24(9),583-591","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1469-0691.2004.00956.x","volume":"10","author":"Soo Y.O.","year":"2004","unstructured":"Soo Y.O.; Cheng Y.; Wong R.; Hui D.S.; Lee C.K.; Tsang K.K.; Ng M.H.; Chan P.; Cheng G.; Sung J.J.; Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect 2004,10(7),676-678","journal-title":"Clin Microbiol Infect"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI138745","volume":"130","author":"Bloch E.M.","year":"2020","unstructured":"Bloch E.M.; Shoham S.; Casadevall A.; Sachais B.S.; Shaz B.; Winters J.L.; van Buskirk C.; Grossman B.J.; Joyner M.; Henderson J.P.; Pekosz A.; Lau B.; Wesolowski A.; Katz L.; Shan H.; Auwaerter P.G.; Thomas D.; Sullivan D.J.; Paneth N.; Gehrie E.; Spitalnik S.; Hod E.A.; Pollack L.; Nicholson W.T.; Pirofski L.A.; Bailey J.A.; Tobian A.A.; Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020,130(6),2757-2765","journal-title":"J Clin Invest"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jmv.25961","volume":"92","author":"Rajendran K.","year":"2020","unstructured":"Rajendran K.; Krishnasamy N.; Rangarajan J.; Rathinam J.; Natarajan M.; Ramachandran A.; Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol 2020,92(9),1475-1483","journal-title":"J Med Virol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"19840","DOI":"10.1038\/srep19840","volume":"6","author":"Gu H.","year":"2016","unstructured":"Gu H.; Xie Z.; Li T.; Zhang S.; Lai C.; Zhu P.; Wang K.; Han L.; Duan Y.; Zhao Z.; Yang X.; Xing L.; Zhang P.; Wang Z.; Li R.; Yu J.J.; Wang X.; Yang P.; Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep 2016,6,19840","journal-title":"Sci Rep"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Imai Y.","year":"2005","unstructured":"Imai Y.; Kuba K.; Rao S.; Huan Y.; Guo F.; Guan B.; Yang P.; Sarao R.; Wada T.; Leong-Poi H.; Crackower M.A.; Fukamizu A.; Hui C.C.; Hein L.; Uhlig S.; Slutsky A.S.; Jiang C.; Penninger J.M.; Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005,436(7047),112-116","journal-title":"Nature"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/ncomms4594","volume":"5","author":"Zou Z.","year":"2014","unstructured":"Zou Z.; Yan Y.; Shu Y.; Gao R.; Sun Y.; Li X.; Ju X.; Liang Z.; Liu Q.; Zhao Y.; Guo F.; Bai T.; Han Z.; Zhu J.; Zhou H.; Huang F.; Li C.; Lu H.; Li N.; Li D.; Jin N.; Penninger J.M.; Jiang C.; Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun 2014,5(1),3594","journal-title":"Nat Commun"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","volume":"11","author":"Lei C.","year":"2020","unstructured":"Lei C.; Qian K.; Li T.; Zhang S.; Fu W.; Ding M.; Hu S.; Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig. Nat Commun 2020,11(1),2070","journal-title":"Nat Commun"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"Gautret P.","year":"2020","unstructured":"Gautret P.; Lagier J.C.; Parola P.; Hoang V.T.; Meddeb L.; Mailhe M.; Doudier B.; Courjon J.; Giordanengo V.; Vieira V.E.; Tissot Dupont H.; Honor\u00e9 S.; Colson P.; Chabri\u00e8re E.; La Scola B.; Rolain J.M.; Brouqui P.; Raoult D.; Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020,56(1)","journal-title":"Int J Antimicrob Agents"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"e01815","DOI":"10.1128\/JVI.01815-18","volume":"93","author":"Iwata-Yoshikawa N.","year":"2019","unstructured":"Iwata-Yoshikawa N.; Okamura T.; Shimizu Y.; Hasegawa H.; Takeda M.; Nagata N.; TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol 2019,93(6),e01815-18","journal-title":"J Virol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1128\/JVI.01118-06","volume":"80","author":"B\u00f6ttcher E.","year":"2006","unstructured":"B\u00f6ttcher E.; Matrosovich T.; Beyerle M.; Klenk H.D.; Garten W.; Matrosovich M.; Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 2006,80(19),9896-9898","journal-title":"J Virol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/2159-8290.CD-20-0451","volume":"10","author":"Stopsack K.H.","year":"2020","unstructured":"Stopsack K.H.; Mucci L.A.; Antonarakis E.S.; Nelson P.S.; Kantoff P.W.; TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention? Cancer Discov 2020,10(6),779-782","journal-title":"Cancer Discov"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003774","volume":"9","author":"Hatesuer B.","year":"2013","unstructured":"Hatesuer B.; Bertram S.; Mehnert N.; Bahgat M.M.; Nelson P.S.; P\u00f6hlmann S.; Schughart K.; Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog 2013,9(12)","journal-title":"PLoS Pathog"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mce.2009.12.022","volume":"317","author":"Mikkonen L.","year":"2010","unstructured":"Mikkonen L.; Pihlajamaa P.; Sahu B.; Zhang F.P.; J\u00e4nne O.A.; Androgen receptor and androgen-dependent gene expression in lung. Mol Cell Endocrinol 2010,317(1-2),14-24","journal-title":"Mol Cell Endocrinol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","volume":"31","author":"Montopoli M.","year":"2020","unstructured":"Montopoli M.; Zumerle S.; Vettor R.; Rugge M.; Zorzi M.; Catapano C.V.; Carbone G.M.; Cavalli A.; Pagano F.; Ragazzi E.; Prayer-Galetti T.; Alimonti A.; Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol 2020,31(8),1040-1045","journal-title":"Ann Oncol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.18433\/jpps31069","volume":"23","author":"Suba Z.","year":"2020","unstructured":"Suba Z.; Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci 2020,23(1),75-85","journal-title":"J Pharm Pharm Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2147\/DDDT.S84437","volume":"9","author":"Suba Z.","year":"2015","unstructured":"Suba Z.; DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers. Drug Des Devel Ther 2015,9,2663-2675","journal-title":"Drug Des Devel Ther"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"Zhu F-C.","year":"2020","unstructured":"Zhu F-C.; Li Y.H.; Guan X.H.; Hou L.H.; Wang W.J.; Li J.X.; Wu S.P.; Wang B.S.; Wang Z.; Wang L.; Jia S.Y.; Jiang H.D.; Wang L.; Jiang T.; Hu Y.; Gou J.B.; Xu S.B.; Xu J.J.; Wang X.W.; Wang W.; Chen W.; Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 2020,395(10240),1845-1854","journal-title":"Lancet"},{"author":"van Doremalen N.","key":"ref=97","unstructured":"van Doremalen N.; Lambe T.; Spencer A.; Belij-Rammerstorfer S.; Purushotham J.N.; Port J.R.; Avanzato V.; Bushmaker T.; Flaxman A.; Ulaszewska M.; Feldmann F.; Allen E.R.; Sharpe H.; Schulz J.; Holbrook M.; Okumura A.; Meade-White K.; P\u00e9rez-P\u00e9rez L.; Bissett C.; Gilbride C.; Williamson B.N.; Rosenke R.; Long D.; Ishwarbhai A.; Kailath R.; Rose L.; Morris S.; Powers C.; Lovaglio J.; Hanley P.W.; Scott D.; Saturday G.; de Wit E.; Gilbert S.C.; Munster V.J.; ChAdOx1 nCoV-19\nvaccination prevents SARS-CoV-2 pneumonia in rhesus macaques.\nbioRxiv, 2020, 2020.05.13.093195."},{"key":"ref=98","first-page":"1","author":"Cassese E.C.","year":"2020","unstructured":"Cassese E.C.; Farhart C.E.; Miller J.M.; Gender differences in COVID-19 conspiracy theory beliefs. Polit Gend 2020,1-12","journal-title":"Polit Gend"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"113","DOI":"10.46234\/ccdcw2020.032","volume":"2","author":"Surveillances V.","year":"2020","unstructured":"Surveillances V.; The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)\u2014China, 2020. China CDC Weekly 2020,2(8),113-122","journal-title":"China CDC Weekly"},{"key":"ref=100","unstructured":"National Committee on COVID-19 Epidemiology, Ministry of Health and Medical Education, IR Iran Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 22, 2020. Arch Acad Emerg Med, 2020, 8(1), e32."},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"Chu C.M.","year":"2004","unstructured":"Chu C.M.; Cheng V.C.; Hung I.F.; Wong M.M.; Chan K.H.; Chan K.S.; Kao R.Y.; Poon L.L.; Wong C.L.; Guan Y.; Peiris J.S.; Yuen K.Y.; Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004,59(3),252-256","journal-title":"Thorax"},{"key":"ref=102","volume":"8","author":"Rismanbaf A.","year":"2020","unstructured":"Rismanbaf A.; Potential treatments for COVID-19; A narrative literature review. Arch Acad Emerg Med 2020,8(1)","journal-title":"Arch Acad Emerg Med"},{"key":"ref=103","first-page":"147","volume":"49","author":"Xu K.","year":"2020","unstructured":"Xu K.; Management of corona virus disease-19 (COVID-19): The zhejiang experience. J Zhejiang Uni(Medical Science), 2020,49(1),147-157","journal-title":"J Zhejiang Uni(Medical Science),"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526521666210322160038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/192415\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526521666210322160038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:20:37Z","timestamp":1656580837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/192415\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526521666210322160038","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e220321192415"}}